<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="infectious virus has severely affected various parts of China, Italy," exact="Spain" post="and USA among others. The prophylactic solution against SARS-CoV-2"/>
 <result pre="only ways to restrict COVID-19outcome[ 3]. Surfacing of SARS-CoV-2 in" exact="China" post="was reported recently on December, 2019 and therefore very"/>
 <result pre="population coverage of &amp;gt;;99% throughout the world. Five countries including" exact="United States" post="and France showed 100% population coverage while ≥95% of"/>
 <result pre="&amp;gt;;99% throughout the world. Five countries including United States and" exact="France" post="showed 100% population coverage while ≥95% of population was"/>
 <result pre="while ≥95% of population was covered in rest countries except" exact="United Kingdom" post="depicting the broad range spectrum of the constructed vaccine"/>
 <result pre="outbreak. Proceedings of the National Academy of Sciences of the" exact="United States" post="of America. 2020. [2]. ↵ Sohrabi C , Alsafi"/>
 <result pre="for development of peptide-based vaccines and cellular immunity assessment methods." exact="Hong Kong" post="medical journal = Xianggang yi xue za zhi. 2011;"/>
</results>
